News | March 25, 2023
Quantumzyme receives patent for development of green catalyst in India
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
A pharma industry veteran with over three decades of experience in domestic as well as international markets
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Subscribe To Our Newsletter & Stay Updated
